Health Desk: The Covid infection is once again increasing all over the world including India. Meanwhile, cases of sub-variants BA.4 and BA.5 of the Omicron variant of Corona have been reported. The BA.4 and BA.5 sub-variants of Omicron have knocked in India. Cases of this sub-variant are also coming in the UK. Meanwhile, a UK agency has detected new symptoms of infection from the new sub-variant.
According to the report of The Independent, Covid cases of Omicron BA.5 variants are increasing rapidly in the UK. Most of the patients infected with this variant have complained of sleeplessness at night and profuse sweating while sleeping. Professor Luke O’Neill of Trinity College Dublin told an Irish radio station earlier this week: “An additional symptom of the BA.5 variant I noticed this morning…. night sweats.”
Answering the question why people are showing these new symptoms? Prof O’Neill said, “This disease is a little different, because the virus has changed its form again.”
He said, “However, there is some immunity in it as well. Immunity is clearly building up with T-cells. Similarly, your weak immunity system and the virus’s slightly different nature can lead to death. If you are sweating a lot while sleeping at night, then be alert. Do get your Covid test done.
Prof O’Neill said, “The very important thing is that if you are fully vaccinated and have also taken a booster dose, then you do not have to fear. Even if the infection does occur, there will be very mild symptoms.
Also read: Monkeypox threat deepens, Spain records first virus death, 70% of cases in Europe
What does the new study say?
However, a new study published in Nature has shown that Kovid-19 vaccines are four times more resistant against this variant. This means that people who have not yet been vaccinated or have not taken a booster dose are four times more likely to be infected with the sub-variant. Whereas the chances of being hospitalized are 7.5 times more. Also, the probability of death is 14 to 15 times.
South Africa got this variant
BA.5 was first discovered in South Africa in February. This sub-variant was confirmed a month after the BA.4 was identified in the same country. From here both these sub-variants have spread across the world. Its infection is spreading rapidly in Britain and Europe. Cases have also been found in America.
